American Fusion, Inc. 8-K

What Happened

• American Fusion, Inc. (AMFN) reported that between January 1 and May 1, 2026 it entered a Master Prepaid Common Stock Purchase Warrant Agreement with a single institutional accredited investor establishing a prepaid warrant financing facility of up to $3,000,000. As of the 8-K filing, the investor has funded approximately $793,000 through multiple prepaid tranches; up to $2,207,000 remains available subject to the agreement.
• The Warrants issued under the facility carry a fixed exercise price of $0.05 per share, do not reset or ratchet with market price, and contain no variable-rate or floating conversion features. The full purchase price for each tranche is prepaid by the investor and no additional consideration is payable upon exercise.
• In a May 4, 2026 press release, the company also announced a reduction in authorized common shares from 3,000,000,000 to 1,800,000,000, following the prior cancellation of approximately 1.683 billion shares and leaving issued and outstanding shares at about 1.316 billion.

Key Details

• Prepaid warrant facility size: up to $3,000,000; funded to date: ≈ $793,000; remaining potential funding: ≈ $2,207,000.
• Warrant exercise price: $0.05 per share; warrants are prepaid and contain no floating or adjustable features.
• Authorized common shares reduced to 1,800,000,000 from 3,000,000,000; issued & outstanding ≈ 1,316,000,000.
• The sales of warrants/shares were reported as unregistered (see Item 3.02); company will file the agreement as an exhibit in a future periodic report.

Why It Matters

• Capital and dilution: The facility gives AMFN access to potential institutional capital without immediate dilution until warrants are exercised. If the full $3.0M were funded and those warrants exercised at $0.05, that would represent up to 60,000,000 additional shares; the $793,000 funded to date could convert to roughly 15.86 million shares if exercised. Investors should watch future tranche funding and any warrant exercises for dilution impact.
• Funding uncertainty: Funding is at the investor’s discretion and the company cannot compel additional tranches, so the $3.0M is potential, not guaranteed.
• Corporate housekeeping: Reducing authorized shares aligns the company’s charter with its current issued share count and near-term needs, potentially reducing administrative overhang from excess authorized capacity.
• Regulatory/liquidity note: The securities were issued in unregistered transactions, which may affect transferability and liquidity until any registration or resale exemptions apply.